Aligning Science Across Parkinson's Logo Text

Consortia

Scientific progress can be accelerated when the community works together in a collaborative, rather than competitive manner. Aligning Science Across Parkinson’s (ASAP) is proud to coordinate with other organizations that promote the sharing of knowledge and resources for the scientific community. Membership in these organizations allows us to work together with the research community to accelerate scientific advances by fostering a collaborative and open approach to research.
Learn more about our memberships below.

Memberships

Research Software Alliance

Research Software Alliance

ASAP is proud to join the Research Software Alliance (ReSA) as an organizational member. ReSA is dedicated to advancing the research software ecosystem by collaborating with decision-makers and key influencers.

Explore

Plan S

Plan S

ASAP is a proud member of Plan S, an initiative for Open Access publishing. The plan is supported by cOAlition S, an international consortium of research funding and performing organizations. Plan S requires that, from 2021, scientific publications that result from research funded by public grants must be published in compliant Open Access journals or platforms.

Explore

Open Research Funders Group

Open Research Funders Group

ASAP is proud to join alongside philanthropic organizations as a member of The Open Research Funders Group (ORFG). ORFG is a partnership of funding organizations committed to the open sharing of research outputs and other forms of scholarship. The ORFG has two primary programmatic pillars: (1) engaging philanthropies in a community of practice to develop, implement, oversee, and advance strategies that accelerate access to funded research, including papers and data; and (2) serving as the funders’ voice in cross-sector discussions about open research policies, incentives, infrastructure, and good practices.

Explore

AMP® PDRD

AMP® PDRD

The Accelerating Medicine Partnership in Parkinson’s Disease and Related Disorders (AMP® PDRD) is a public-private partnership between the National Institutes of Health (NIH), multiple biopharmaceutical and life science companies, and nonprofit organizations. Managed through the Foundation for the NIH (FNIH), AMP® PDRD aims to harmonize Parkinson’s and related disease datasets across the community with the goal of identifying and validating diagnostic, prognostic, and/or progression biomarkers for Parkinson’s disease, with an emphasis on broadening data sharing in the biomedical community to advance Parkinson’s research. ASAP is proud to be a partner in the AMP® PDRD effort to broaden data sharing in the biomedical community to advance Parkinson’s research. Both GP2 and PPMI cohorts share their data on this platform.

Explore

News & Updates

Our initiative is accelerating the pace of discovery for Parkinson’s disease through collaboration, research-enabling resources, and data sharing.

The Components of GP2’s 12th Data Release
The Components of GP2’s 12th Data Release

June 30, 2026

In July 2026, GP2 announced the 12th data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PDRD. This release includes 21,156 additional genotyped participants and 25,046 additional whole genome sequencing (WGS) participants.

Learn More
Endolysosomal Pathways in Parkinson’s Disease: Highlights from the 2025 Cell Biology of Parkinson’s Disease Conference
Endolysosomal Pathways in Parkinson’s Disease: Highlights from the 2025 Cell Biology of Parkinson’s Disease Conference

June 16, 2026

In this blog, ASAP shares highlights from the 2025 Cell Biology of Parkinson’s Disease Conference that brought together investigators and trainees to discuss the intricacies of Parkinson’s disease at the cellular level.

Learn More
Cloudy With a Chance of Multi-Omics: Expanding the CRN Cloud to Facilitate Parkinson’s Research
Cloudy With a Chance of Multi-Omics: Expanding the CRN Cloud to Facilitate Parkinson’s Research

June 10, 2026

In this blog, ASAP discusses the expansion of the CRN Cloud platform, which has grown to house over 50 harmonized multi-omics datasets while integrating new interoperability features and analysis tools to streamline collaboration across the Parkinson’s research community.

Learn More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.